July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Valproic Acid Reduces Inflammation following Experimental Glaucoma Surgery
Author Affiliations & Notes
  • Tina Wong
    Singapore Eye Research Institute, Singapore, Singapore
    Duke NUS Graduate Medical School, Singapore, Singapore
  • Li Zhen Toh
    Singapore Eye Research Institute, Singapore, Singapore
  • Stephanie Chu
    Singapore Eye Research Institute, Singapore, Singapore
  • Li Fong Seet
    Singapore Eye Research Institute, Singapore, Singapore
    Duke NUS Graduate Medical School, Singapore, Singapore
  • Footnotes
    Commercial Relationships   Tina Wong, None; Li Zhen Toh, None; Stephanie Chu, None; Li Fong Seet, None
  • Footnotes
    Support  NMRC/TCR/002-SERI/2008
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 477. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tina Wong, Li Zhen Toh, Stephanie Chu, Li Fong Seet; Valproic Acid Reduces Inflammation following Experimental Glaucoma Surgery. Invest. Ophthalmol. Vis. Sci. 2018;59(9):477.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : We have previously demonstrated that valproic acid (VPA) was effective in suppressing collagen production in conjunctival wound healing. The purpose of this study aims to further determine the effect of VPA on the inflammatory response following experimental glaucoma filtration surgery (GFS).

Methods : Following GFS in the mouse, VPA at 300 μg/ml in 5 μl volume was injected subconjunctivally adjacent the operated site at the end of surgery . PBS was injected in parallel experiments as controls. Blebs were harvested and pooled into 5 groups (n=5) on day 2 post-surgery to assess the inflammatory response, which is measured by cytokine levels, macrophage infiltration and capacity of VPA to suppress the effects of archetypal tumor necrosis factor-alpha, TNF-α, on primary mouse conjunctival fibroblasts. Cytokines were determined using the MCYTOMAG-70K multiplex assay. Macrophages were measured by flow cytometry analysis of CD45/ F4/80-labeled cells. Mouse conjunctival fibroblasts were treated with TNF-α for 48 h before the culture supernatants were recovered for cytokine analysis. Statistical analyses were performed by using either the two-tailed Student’s t-test or one-way ANOVA.

Results : VPA-treated blebs contained significantly less chemokines (CXCL1 and CCL2), interleukins (IL-1α, IL-1β, -2, -5, -6, -9, -10, and -15), and cytokines (GM-CSF and M-CSF). Notably, IL-5, -6, -10 were reduced by more than 2-fold compared to PBS controls. VPA also reduced the recruitment of CD45+F4/80+ cells by 3-10% (mean 6.5% reduction, p=0.0055). In fibroblasts co-treated with TNF-α, VPA significantly suppressed TNF-α induction of chemokines (CCL2, CCL5, and CCL10), interleukins (IL-1α, IL-1β, -2, -5, -10, -12 and -15) and other cytokines (VEGF, IFN-γ). Comparing TNF-α alone with TNF-α and VPA combined treatment, CCL5 was the most suppressed chemokine, by 4.89-fold, (p=3.70e-15).

Conclusions : VPA has the capacity to suppress the inflammatory response by reducing the production of a myriad of proinflammatory chemokines and cytokines as well as the recruitment of macrophages following conjunctival wounding. This property, in conjunction with its capacity to suppress collagen production post surgery, proposes VPA to be an effective adjunct to glaucoma filtration surgery for improving surgical success through its actions on the key two stages of wound healing.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.